Eğitim Bilgileri
2001 - 2004
2001 - 2004Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1997 - 2001
1997 - 2001Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Akademik Ünvanlar / Görevler
2013 - Devam Ediyor
2013 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2006 - 2013
2006 - 2013Doç. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Makaleler
Tümü (111)
SCI-E, SSCI, AHCI (99)
SCI-E, SSCI, AHCI, ESCI (107)
ESCI (8)
Scopus (103)
TRDizin (44)
Diğer Yayınlar (3)
2025
20251. Comparison of pain catastrophizing, kinesiophobia, adaptation to artificial joint and functional outcomes following total knee arthroplasty in hemophilia
KINIKLI G. İ., KANLIKAYA U. G., GÖKER B., ÇAĞLAR Ö., TOKGÖZOĞLU A. M., ATİLLA B., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE , 2025 (TRDizin)
2024
20242. Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options
Zulfikar B., Koc B., Sahin F., Sasmaz H. I., Kavakli K., Balkan C., et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
, cilt.8, sa.7, 2024 (SCI-Expanded, Scopus)
2022
20223. Postoperative bleeding adversely affects total knee arthroplasty outcomes in hemophilia
Göker B., Çağlar Ö., Kınıklı G. İ., Aksu S., Tokgözoğlu A. M., Atilla B.
Knee
, cilt.39, ss.261-268, 2022 (SCI-Expanded, Scopus)
2022
20224. Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)
Kaynar L., Tekgunduz E., KOZANOĞLU İ., Ozkan H. A., AKSU S., ÖZKALEMKAŞ F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.61, sa.1, 2022 (SCI-Expanded, Scopus)
2022
20225. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation
KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
20226. Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey
Aydin M. S., Ciftciler R., İNKAYA A. Ç., AKSU S.
GAZI MEDICAL JOURNAL
, cilt.33, sa.1, ss.1-4, 2022 (ESCI, Scopus)
2022
20227. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine
Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
20218. Sarcopenia and anthracycline cardiotoxicity in patients with cancer
BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
20219. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience
Goren Sahin D., Akay O. M., KEKLİK M., Okan V., KARAKUŞ A., Demir C., et al.
ANNALS OF HEMATOLOGY
, cilt.100, ss.1667-1675, 2021 (SCI-Expanded, Scopus)
2021
202110. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia
ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.60, sa.2, 2021 (SCI-Expanded, Scopus)
2021
202111. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors
KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.
CARDIOVASCULAR TOXICOLOGY
, cilt.21, sa.3, ss.216-223, 2021 (SCI-Expanded, Scopus)
2021
202112. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia
ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)
2021
202113. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202114. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis
KEKLİK KARADAĞ F., Yenerel M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH
, cilt.11, sa.3, ss.279-285, 2021 (ESCI)
2020
202015. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.
Transfusion and Apheresis Science
, cilt.59, sa.5, 2020 (SCI-Expanded, Scopus)
2020
202016. Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature
ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.
MEDICINE
, cilt.99, sa.26, 2020 (SCI-Expanded, Scopus)
2020
202017. Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.2, 2020 (SCI-Expanded, Scopus)
2020
202018. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202019. FUNCTIONAL STATUS AND FEAR OF MOVEMENT LEVELS OF HEMOPHILIA A PATIENTS FOLLOWING TOTAL KNEE ARTHROPLASTY
BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., Guney-Deniz H.
HAEMOPHILIA
, cilt.26, ss.171, 2020 (SCI-Expanded, Scopus)
2020
202020. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy
Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
, cilt.42, sa.1, ss.17-21, 2020 (SCI-Expanded, Scopus)
2020
202021. Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
HEMATOLOGY REPORTS
, cilt.12, sa.1, 2020 (ESCI, Scopus)
2020
202022. The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202023. Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201924. Effects of Smoking on Hematological Parameters and Ferritin Levels
Ciftciler R., Guven A., HAZNEDAROĞLU İ. C., AKSU S.
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
, cilt.57, sa.4, ss.372-376, 2019 (ESCI, Scopus, TRDizin)
2019
201925. SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA
ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.94, 2019 (SCI-Expanded, Scopus)
2019
201926. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.11, ss.729-734, 2019 (SCI-Expanded, Scopus)
2019
201927. CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY
BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.
Genetics and Application , cilt.3, sa.1, ss.51-56, 2019 (Hakemli Dergi)
2019
201928. The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.20, sa.2, 2019 (SCI-Expanded, Scopus)
2019
201929. Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., Gokei H.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.5, 2019 (SCI-Expanded, Scopus)
2019
201930. The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.
GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.
Journal Of The Renin-Angiotensin-Aldosterone System , 2019 (SCI-Expanded, Scopus)
2019
201931. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded, Scopus)
2019
201932. Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study
Ciftciler R., AKSU S., Dikmenoglu Falkmarken N., Celalettin Haznedaroglu I.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.1, ss.356-360, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201933. Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia
Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201934. The factors affecting early death in newly diagnosed APL patients
Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE
, cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded, Scopus)
2019
201935. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.2, ss.88-96, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201936. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.5, ss.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201937. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201938. The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
Turk C., OKAY M., TÜRK S., Temirci E. S., Javad O., AKSU S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.2, ss.661-674, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201939. Indications and outcomes of splenectomy for hematological disorders
Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE
, cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus)
2018
201840. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)
2018
201841. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia
KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201842. Combination of novoseven and feiba in hemophiliac patients with inhibitors
Malkan Ü. Y., AKSU S.
OPEN MEDICINE
, cilt.13, sa.1, ss.618-621, 2018 (SCI-Expanded, Scopus)
2017
201743. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia
Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.
LEUKEMIA & LYMPHOMA
, cilt.58, ss.96, 2017 (SCI-Expanded)
2017
201744. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201745. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
TÜRK TÜRK S., Malkan Ü. Y., Ghasemi M., Hocaoglu H., Mutlu D., Gunes G., et al.
SAGE OPEN MEDICINE
, cilt.5, 2017 (ESCI, Scopus)
2017
201746. Bell s palsy as an early manifestation of acute lymphoblastic leukemia
ÖZÇAKAR L., AKINCI TAN F. A., ÖZGÖÇMEN S., AKSU S., ERG Ç.
Annals Of Hematology , 2017 (SCI-Expanded, Scopus)
2016
201647. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201648. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice
Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201649. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias
Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201650. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201651. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma
GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201652. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201553. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia
ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY
, cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)
2015
201554. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology
BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded, Scopus)
2015
201555. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201556. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA
, cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)
2015
201557. Clinicopathological associations of acquired erythroblastopenia
GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)
2015
201558. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201559. The factors affecting early death after the initial therapy of acute myeloid leukemia
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)
2014
201460. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission
Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201461. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management
GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201462. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201463. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)
AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201464. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population
Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.190-194, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201465. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report
MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201466. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature
Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201367. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201368. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.14, sa.4, ss.308-314, 2013 (SCI-Expanded, Scopus)
2013
201369. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)
2013
201370. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201371. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY
, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)
2013
201372. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis
Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)
2013
201373. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201374. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.
ACTA HAEMATOLOGICA
, cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)
2013
201375. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis
Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201276. How do we collect better granulocyte?
Akyol T. K., Buyukasik Y., Aksu S., Ozcebe O. I.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.47, sa.1, ss.107-111, 2012 (SCI-Expanded, Scopus)
2012
201277. Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
UZ B., Ozdemir E., Aksu S., AKYOL T. K., JONES R.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.29, sa.2, ss.199-200, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201278. Discovering Blood Donor Arrival Patterns Using Data Mining: A Method to Investigate Service Quality at Blood Centers
TESTİK M. C., OZKAYA B., AKSU S., ÖZCEBE O. İ.
JOURNAL OF MEDICAL SYSTEMS
, cilt.36, sa.2, ss.579-594, 2012 (SCI-Expanded, SSCI, Scopus)
2012
201279. Histopathological Alterations in the Kidney Tissue Following Topical Ankaferd Hemostat Application in a Rat Renal Injury Model
KARAKOÇ D., Akar E., AKSU S., ÜNER A., ÖZDEMİR A., HAMALOĞLU E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.4, ss.275-281, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201280. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML
AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201281. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL
Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201282. Striking Promotion of the In Vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat
Albayrak M., AKSU S., Celebi H., Albayrak A., Ginis Z., Yagci S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.15-22, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201283. The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia
AKSU S., ŞAHİN F., Uz B., Yavuz S. A., Atay H., KELKİTLİ E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.8-14, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
201184. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
201185. Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation
YALÇIN S. S., Kondolot M., GÖKER H., KUŞKONMAZ B. B., Karacan Y., ÇETİN M., et al.
EPIDEMIOLOGY AND INFECTION
, cilt.139, sa.5, ss.683-687, 2011 (SCI-Expanded, Scopus)
2011
201186. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
, cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)
2011
201187. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)
2011
201188. Inappropiate Fresh Frozen Plasma use in Coagulation Disorders
AKKAŞ M., ataman d. k., AKMAN C., METİN AKSU N., KARACA M. A., AKSU S., et al.
European Journal of Surgical Sciences , cilt.2, sa.2, ss.38-41, 2011 (Hakemli Dergi)
2011
201189. Inappropriate Fresh Frozen Plasma Use in Coagulation Disorder
AKKAŞ M., KÖMÜR ATAMAN D., AKMAN C., METİN AKSU N., KARACA M. A., AKSU S., et al.
European Journal of Surgical Sciences , cilt.2, ss.38-41, 2011 (Hakemli Dergi)
2010
201090. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
201091. Determination of burnout levels of nurses working in stem cell transplantation units in Turkey
AKKUŞ Y., Karacan Y., GÖKER H., AKSU S.
NURSING & HEALTH SCIENCES
, cilt.12, sa.4, ss.444-449, 2010 (SCI-Expanded, SSCI, Scopus)
2010
201092. Serological response to influenza vaccine after hematopoetic stem cell transplantation
YALÇIN Ş., Kondolot M., Albayrak N., Altas A. B., Karacan Y., Kuskonmaz B. B., et al.
ANNALS OF HEMATOLOGY
, cilt.89, sa.9, ss.913-918, 2010 (SCI-Expanded, Scopus)
2010
201093. Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas
Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.96-102, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201094. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis
Kurt M., Akdogan M., Onal I. K., Kekilli M., Arhan M., Shorbagi A., et al.
DIGESTIVE AND LIVER DISEASE
, cilt.42, sa.3, ss.196-199, 2010 (SCI-Expanded, Scopus)
2010
201095. The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia
Ulger Z., AKSU S., Aksoy D. Y., KÖKSAL D., HAZNEDAROĞLU İ. C., Kirazi S.
PLATELETS
, cilt.21, sa.1, ss.49-52, 2010 (SCI-Expanded, Scopus)
2010
201096. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML
BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201097. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)
2010
201098. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations
HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201099. Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report
Ozdemir D., DAĞDELEN S., Erbas T., AĞBAHT K., Serefhanoglu S., AKSU S., et al.
CASE REPORTS IN MEDICINE
, 2010 (ESCI, Scopus)
2010
2010100. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients
Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE
, cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)
2009
2009101. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY
, cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)
2009
2009102. In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract
Akkoc N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.29, sa.2, ss.410-415, 2009 (SCI-Expanded, Scopus)
2008
2008103. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma
Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY
, cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)
2008
2008104. Endoscopic application of Ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report
Kurt M., Disibeyaz S., Akdogan M., Sasmaz N., AKSU S., HAZNEDAROĞLU İ. C.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.103, sa.8, ss.2156-2158, 2008 (SCI-Expanded, Scopus)
2008
2008105. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)
2007
2007106. Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency
Kurt M., Shorbagi A., Aksu S., Haznedaroglu I., Altundag K., Erkin G.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.18, sa.8, ss.805-806, 2007 (SCI-Expanded, Scopus)
2007
2007107. Renin-angiotensin system expression in the K562 human erythroleukaemic cell line
Koca E., Haznedaroglu I. C., Acar K., Beyazit Y., Aksu S., Misirlioglu M., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.8, sa.3, ss.145-147, 2007 (SCI-Expanded, Scopus)
2007
2007108. Alterations in the 'local umbilical cord blood renin-angiotensin system' during pre-eclampsia
Acar K., Beyazit Y., Sucak A., Haznedaroglu I. C., Aksu S., Tuncer S., et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
, cilt.86, sa.10, ss.1193-1199, 2007 (SCI-Expanded, Scopus)
2006
2006109. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML
Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.
LEUKEMIA & LYMPHOMA
, cilt.47, sa.5, ss.891-896, 2006 (SCI-Expanded, Scopus)
2006
2006110. Couda equina syndrome as a rare manifestation of leukemia relapse during postallograft period
Önal I. K., Shorbagi A., GÖKER H., Büyükasyk Y., ÖZÇAKAR L., Tufan A., et al.
Journal of the National Medical Association
, cilt.98, sa.5, ss.808-810, 2006 (SCI-Expanded, Scopus)
2006
2006111. Unilateral diaphragm paralysis possibly due to cervical spine involvement in multiple myeloma
Kara M., Isik M., Ozcakar L., Erol O., Dogan S., Altundag K., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.15, sa.3, ss.242-244, 2006 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. EŞLEŞTİRİLMİŞ KOHORT ÇALIŞMASI: HEMOFİLİ HASTALARINDA TOTAL DİZ ARTROPLASTİSİ SONRASI AĞRI KATASTROFİZASYONU, KİNEZYOFOBİ, YAPAY EKLEM UYUMU VE FONKSİYONEL SONUÇLAR
KANLIKAYA U. G., GÖKER B., ATİLLA B., TOKGÖZOĞLU A. M., ÇAĞLAR Ö., KINIKLI G. İ., et al.
“33. Ulusal Türk Ortopedi ve Travmatoloji Kongresi”, Antalya, Türkiye, 29 Eylül 2024, (Özet Bildiri)
2024
20242. Impacts on Functional Outcomes Following Total Knee Arthroplasty in Hemophilia Patients: A Comparative Study of Pain Catastrophizing and Adaptation to Artificial Joints
KANLIKAYA U. G., KINIKLI G. İ., GÖKER B., ATİLLA B., ÇAĞLAR Ö., TOKGÖZOĞLU A. M., et al.
EAHAD2024, Frankfurt, Almanya, 6 - 09 Şubat 2024, cilt.30, ss.94, (Özet Bildiri)
2024
20243. Pain Catastrophizing, Kinesiophobia, Adaptation To Artificial Joint And Functional Outcomes Following Total Knee Arthroplasty In Hemophilia: A Matched Cohort Study
KANLIKAYA U. G., GÖKER B., KINIKLI G. İ., ATİLLA B., TOKGÖZOĞLU A. M., ÇAĞLAR Ö., et al.
25th EFORT CONGRESS, Hamburg, Almanya, 31 Ocak 2024, (Özet Bildiri)
2020
20204. Demir Eksikliği Anemisi Tanısı Alan HastalarınTedavi Öncesi ve Sonrası Yaşam Kalitesinin Değerlendirilmesi
BEŞE T., AYHAN BAŞER D., AKSU S.
Ulusal Aile Hekimliği Kongresi 2020 (19. Ulusal Aile Hekimliği Kongresi), Online, Türkiye, 29 Ekim - 01 Kasım 2020, (Özet Bildiri)
2020
20205. FUNCTIONAL STATUS AND FEAR OF MOVEMENT LEVELS OF HEMOPHILIA A PATIENTS FOLLOWING TOTAL KNEE ARTHROPLASTY
BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., GÜNEY DENİZ H.
EAHAD2020/NETHERLANDS, The Hague, Hollanda, 5 - 07 Şubat 2020, (Özet Bildiri)
2020
20206. Abstracts
BOZGEYİK S., KINIKLI G. İ., AKSU S., ATİLLA B., GÜNEY DENİZ H.
EAHAD2020, The Hague, Hollanda, 03 Şubat 2020, cilt.26, (Özet Bildiri)
2019
20197. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE
SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, İsviçre, 18 - 22 Haziran 2019, cilt.37, ss.366, (Özet Bildiri)
2019
20198. ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ
AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
20199. ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
201910. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Türkiye, 8 - 09 Mart 2019, (Özet Bildiri)
2018
201811. Alt Ekstremite Artropatisi Olan ve Olmayan Hemofilik Bireylerin Yaşam Kalitesi, Depresyon ve Anksiyete Seviyelerinin Karşılaştırılması
AYKAR S., CAN F., AKSU S.
28. Ulusal Türk Ortopedi ve Travmatoloji Kongresi, Türkiye, 30 Ekim - 04 Kasım 2018, (Özet Bildiri)
2018
201812. Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients
ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)
2018
201813. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM
DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201814. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.364-365, (Özet Bildiri)
2018
201815. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI
ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.261, (Özet Bildiri)
2018
201816. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM
MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192, (Özet Bildiri)
2018
201817. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.266, (Özet Bildiri)
2018
201818. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
2018
201819. Descriptive analysis of myeloproliferative diseases and its complications
OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
2018
201820. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)
2018
201821. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018, (Özet Bildiri)
2018
201822. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Kıbrıs (Kktc), 19 - 23 Eylül 2018, ss.254, (Özet Bildiri)
2018
201823. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, (Özet Bildiri)
2018
201824. PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201825. KINESIOPHOBIA, QUALITY OF LIFE, DEPRESSION AND ANXIETY LEVEL IN ADULT HEMOPHILIAC PATIENTS: A CONTROLLED STUDY
AYKAR S., CAN F., AKSU S.
EAHAD 2018, 7 - 09 Şubat 2018, cilt.24, ss.32-135, (Özet Bildiri)
2017
201726. Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation
KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.
59th ASH, 9 - 12 Aralık 2017, cilt.130, ss.5521, (Özet Bildiri)
2017
201727. Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation
KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.
LYMPHOMA AND MYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.43-44, (Özet Bildiri)
2017
201728. Donor Lymphocyte Infusions: Single Center Experience
KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.
LYMPHOMAMYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.48, (Özet Bildiri)
2017
201729. Donor Lymhocyte Infusion: Single Center Experience
KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.
LYMHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)
2017
201730. Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation
KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.
LYMPHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)
2018
201831. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, cilt.53, (Tam Metin Bildiri)
2017
201732. Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.
malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.
XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Almanya, 08 Temmuz 2017 - 13 Ocak 2018, cilt.1, ss.402, (Özet Bildiri)
2017
201733. The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia
OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.
iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017, (Özet Bildiri)
2017
201734. Ayak Bileği Burkulması Olan Bir Hemofili Hastasında Kuvvetlendirme Egzersizleri, Manuel Tedavi ve Proprioseptif Eğitimin Ağrı, Ayak Fonksiyonları ve Hareket Korkusuna Olan Etkisi.
ÖNAL S., CAN F., AKSU S.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)
2015
201535. BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT
Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201536. AN ACUTE MYELOID LEUKEMIA PATIENT COMPLICATED WITH HYPERLEUKOCYTOSIS
Malkan Ü. Y., GÜNEŞ G., Yayar O., HAZNEDAROĞLU İ. C., AKSU S., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201537. TREATMENT OF PYODERMA GANGRENOSUM WITH THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: A CASE REPORT
Malkan Ü. Y., GÜNEŞ G., Yayar O., Aslan T., AKSU S., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201538. A PLASMA CELL LEUKEMIA CASE
Malkan Ü. Y., GÜNEŞ G., ETGÜL S., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201539. THERAPY-RELATED MYELODYSPLASTIC SYNDROME AFTER THE SUCCESSFUL TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
Malkan Ü. Y., GÜNEŞ G., Yayar O., AKSU S., DEMİROĞLU H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201540. A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINE
Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201541. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)
2015
201542. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors
Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201443. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201444. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)
2010
201045. Serological response to influenza vaccine haematopoetic stem cell transplantation patients
YALÇIN Ş., Kondolot M., Albayrak N., Altas B., Karacan Y., KUŞKONMAZ B. B., et al.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45, (Özet Bildiri)